Answers are grounded in this paper and cite their sources.
In recent decades, a cocktail of different anticancer therapies has aroused intensive interest of many researchers. Drug delivery systems (DDS) based on nanoplatforms have exhibited great potential in this field. In this work, a novel photothermal DDS was designed with ZrO 2 -coated MoO 2 , which capped with Bi 2 O 3 and modified with AS1411 aptamer. The photosensitizer, chlorin e6 (Ce6), was successfully delivered to the tumor sites by the designed DDS. Bi 2 O 3 endows the nanoplatform with the ability of releasing Ce6 rapidly in tumor microenvironment while the AS1411 aptamer can target the nucleolin overexpressed on the tumors. The drug-loaded nanoagent exhibits great photothermal conversion ability, good tumor targeting, and better anti-cancer effects than the individual therapy both in vitro and in vivo . This work explores a new route for photothermal-photodynamic combined therapy and a new treatment modality for tumor ablation.
No takes yet. Share an insight, caveat, or question.
Lü et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: